Old drugs for jak-stat pathway inhibition in COVID-19

MR Dayer - arXiv preprint arXiv:2010.12332, 2020 - arxiv.org
The pandemic threat of COVID-19 with more than 37 million cases in which about 5 percent
entering critical stage characterized by cytokine storm and hyperinflammatory condition, the …
被引用次数：2 相关文章

Old Drugs for JAK-STAT Pathway Inhibition in COVID-19

MR Dayer - arXiv e-prints, 2020 - ui.adsabs.harvard.edu
The pandemic threat of COVID-19 with more than 37 million cases in which about 5 percent
entering critical stage characterized by cytokine storm and hyperinflammatory condition, the …
[PDF] researchgate.net

[PDF][PDF] Old Drugs for JAK-STAT Pathway Inhibition in COVID-19 Patients

MR Dayer - researchgate.net
The pandemic threat of COVID-19 with more than 37 million cases in which about 5 percent
entering critical stage characterized by cytokine storm and hyperinflammatory condition, the …
[HTML] europepmc.org

[HTML][HTML] Old Drugs for JAK-STAT Pathway Inhibition in COVID-19

MR Dayer - 2020 - europepmc.org
The pandemic threat of COVID-19 with more than 37 million cases in which about 5 percent
entering critical stage characterized by cytokine storm and hyperinflammatory condition, the …